Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-400 based artificial tear vs. Systane for post-LASIK dry eye
NCT00620893Phase 4Completed
- Sponsor
- BP Consulting
- Start
- Feb 2008
- Primary completion
- May 2009
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of polyethylene glycol 400 in dry eye syndrome (DED), sponsored by BP Consulting. Started Feb 2008; status: completed.
02
Drugs
polyethylene glycol 400
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00620893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00620893.